Published in J Clin Microbiol on June 01, 2003
Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol (2004) 2.20
PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. J Clin Microbiol (2004) 1.34
Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2005) 1.05
Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years. J Clin Microbiol (2014) 1.00
Molecular discrimination between Neisseria meningitidis serogroups W-135 and Y based on the nucleotide recognition domain sequence of the capsule polymerases. J Clin Microbiol (2010) 0.92
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections. J Clin Microbiol (2015) 0.84
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun (2001) 2.86
Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect (1997) 2.67
Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis (2000) 1.97
Meningococcal conjugate vaccines: new opportunities and new challenges. Lancet (1999) 1.93
Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules. Mol Gen Genet (1997) 1.68
siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett (1998) 1.61
Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis. J Clin Microbiol (2001) 1.31
Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci. Med Microbiol Immunol (1997) 1.15
Rapid assignment of nucleotide sequence data to allele types for multi-locus sequence analysis (MLSA) of bacteria using an adapted database and modified alignment program. J Mol Microbiol Biotechnol (2002) 1.09
Meningococcal disease. J Med Microbiol (1993) 1.00
Laboratory confirmation of meningococcal disease in Scotland, 1993-9. J Clin Pathol (2002) 0.88
Implications for the serogroup incidence of meningococcal disease after the introduction of the MenC vaccine. Scott Med J (2000) 0.84
Interruption of siaD in a meningococcal carrier isolate mediated by an insertion sequence. Clin Diagn Lab Immunol (2001) 0.83
The epidemiology and control of invasive meningococcal disease. Pediatr Infect Dis J (1999) 0.81
Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine (2012) 1.28
Comparison of commercial DNA extraction kits for extraction of bacterial genomic DNA from whole-blood samples. J Clin Microbiol (2003) 1.17
Tyrosine phosphorylation in Escherichia coli. J Mol Biol (1998) 1.13
Rapid assignment of nucleotide sequence data to allele types for multi-locus sequence analysis (MLSA) of bacteria using an adapted database and modified alignment program. J Mol Microbiol Biotechnol (2002) 1.09
Dynamics of pneumococcal colonization in healthy Dutch children. Microbiology (2006) 1.05
Continued control of pneumococcal disease in the UK - the impact of vaccination. J Med Microbiol (2010) 1.01
Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit--a systematic review of risk factors and environmental sources. J Med Microbiol (2012) 1.00
Automation of MLST using third-generation liquid-handling technology. Mol Biotechnol (2006) 0.97
Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J Clin Microbiol (2009) 0.96
Evaluation of a fluorescence-based PCR method for identification of serogroup a meningococci. J Clin Microbiol (2003) 0.94
Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland, 1999-2002. J Med Microbiol (2005) 0.91
Automation of fluorescence-based PCR for confirmation of meningococcal disease. J Clin Microbiol (2001) 0.90
Changes in cesarean delivery in the United States, 1988 and 1993. Birth (1995) 0.89
State variation in rates of cesarean and VBAC delivery: 1989 and 1993. Stat Bull Metrop Insur Co (1996) 0.85
Molecular analysis of Streptococcus pneumoniae clones causing invasive disease in children in Singapore. J Med Microbiol (2011) 0.84
A single nucleotide polymorphism identification assay for the genotypic characterisation of Neisseria meningitidis using MALDI-TOF mass spectrometry. Br J Biomed Sci (2004) 0.84
Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK. J Med Microbiol (2010) 0.84
Identification of novel pneumolysin alleles from paediatric carriage isolates of Streptococcus pneumoniae. J Med Microbiol (2010) 0.84
Detection and genotyping of meningococci using a nested PCR approach. J Med Microbiol (2003) 0.83
Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media. J Clin Microbiol (2005) 0.83
Factors influencing primary cesarean rates. JAMA (1994) 0.82
Sampling methods for the study of pneumococcal carriage: a systematic review. Vaccine (2012) 0.80
Semi-automation of the polymerase chain reaction for laboratory confirmation of meningococcal disease. Br J Biomed Sci (2002) 0.80
Truncated xpt gene present in invasive Streptococcus pneumoniae may have implications for MLST schemes. J Med Microbiol (2005) 0.79
Nucleotide sequence analysis of the sialyltransferase genes of meningococcal serogroups B, C, Y and W135. J Mol Microbiol Biotechnol (2003) 0.79
Distribution of epidemic antibiotic-resistant pneumococcal clones in Scottish pneumococcal isolates analysed by multilocus sequence typing. Microbiology (2006) 0.79
Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: possible implications for UK vaccine policy. Eur J Clin Microbiol Infect Dis (2005) 0.79
TypA is a virulence regulator and is present in many pathogenic bacteria. Br J Biomed Sci (2003) 0.79
Human infection with Cyclospora. J Infect (1994) 0.78
Cyclospora cayetanensis infection: vegetables and water as possible vehicles for its transmission in Lagos, Nigeria. Br J Biomed Sci (2003) 0.77
Factors influencing medical interns trained at U.W.I. to work subsequently in a rural area in Jamaica. West Indian Med J (1992) 0.77
Cyclospora cayetanensis in stools submitted to hospitals in Lagos, Nigeria. Int J Infect Dis (2002) 0.76
An attempt to demonstrate a serological immune response in patients infected with Cyclospora cayetanensis. Br J Biomed Sci (1997) 0.76
Cyclospora cayetanensis infection in Lagos, Nigeria. Clin Microbiol Infect (2003) 0.76
Contamination of crystal violet in the gram stain method. J Clin Pathol (1995) 0.75
Why do microbes have toxins? Symp Ser Soc Appl Microbiol (1998) 0.75
Remarriages: a demographic profile. J Fam Issues (1992) 0.75
Book Reviews. Br J Biomed Sci (2006) 0.75
Trends and characteristics of births attended by midwives. Stat Bull Metrop Insur Co (1997) 0.75
Incidental laboratory diagnosis of Cyclospora cayetanensis. Br J Biomed Sci (1996) 0.75
Laboratory diagnosis and autofluorescence of Cyclospora. Br J Biomed Sci (1995) 0.75
Evaluation of PCR-based approach for serotype determination of Streptococcus pneumoniae. Trop Biomed (2013) 0.75
Clinical aspects of pneumonia. Br J Biomed Sci (2002) 0.75
Percutaneous myocardial laser revascularisation. Heart (2000) 0.75
Book Reviews. Br J Biomed Sci (2004) 0.75
Birth and fertility rates for states: United States, 1990. Vital Health Stat 21 (1994) 0.75
Myocardial laser revascularization. Eur Heart J (1999) 0.75
Rates of cesarean and VBAC delivery, United States, 1994. Birth (1996) 0.75
Whole gene pneumolysin PCR can be used as a diagnostic assay but cannot predict serotype. Br J Biomed Sci (2004) 0.75
Comparative bone marrow study using two aspiration needles and two biopsy sites. J Am Osteopath Assoc (1966) 0.75